» Articles » PMID: 11215597

Changes in Vocal Loudness Following Intensive Voice Treatment (LSVT) in Individuals with Parkinson's Disease: a Comparison with Untreated Patients and Normal Age-matched Controls

Overview
Journal Mov Disord
Date 2001 Feb 24
PMID 11215597
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

This study assessed the impact of the Lee Silverman Voice Treatment (LSVT) on vocal loudness [sound pressure level (SPL)] in a group of dysarthric individuals with idiopathic Parkinson's disease (IPD). Pre- to post-treatment changes in SPL in the treated group were compared with changes in voice SPL during the same time in two control groups: individuals with IPD not treated with the LSVT and in non-disordered individuals, age-matched to the patients. All subjects produced the same voice and speech tasks--sustaining vowel phonation, reading the "Rainbow Passage," producing a short monologue, and describing a picture. These tasks were recorded at three different occasions: just prior to treatment, just after treatment, and 6 months following treatment. The individuals treated with LSVT increased voice SPL from baseline to post-treatment by an average of 8 dB and from baseline to 6 months follow-up by an average of 6 dB. These changes were statistically significant and perceptibly audible. No significant changes in SPL were observed in the control groups during the time corresponding to the treatment and follow-up. Differences in SPL between the treated and untreated patients at post-treatment and follow-up were statistically significant for all voice and speech tasks. These findings, along with others, provide additional support for the efficacy of the LSVT.

Citing Articles

Efficacy of in-person and telepractice-based extended Lee Silverman Voice Treatment LOUD on dysarthria and dysphagia in adults with cerebral palsy.

Kim K, Park S, Hwang S, Park A, Kim H, Hwang J Digit Health. 2025; 11:20552076251315296.

PMID: 39896269 PMC: 11786291. DOI: 10.1177/20552076251315296.


The Effectiveness of Lee Silverman Voice Treatment (LSVT LOUD) on Children's Speech and Voice: A Scoping Review.

Papadopoulos A, Voniati L, Ziavra N, Tafiadis D Brain Sci. 2024; 14(9).

PMID: 39335431 PMC: 11429989. DOI: 10.3390/brainsci14090937.


Telerehabilitation for Lee Silverman Voice Treatment (Tele-LSVT)-Loud on voice intensity and voice use in daily living in people with multiple sclerosis: A protocol for a feasibility and pilot randomized controlled study.

Vitali C, Fusari G, Baldanzi C, Cacciatore D, Crispiatico V, Carullo A Digit Health. 2023; 9:20552076231218150.

PMID: 38074343 PMC: 10702413. DOI: 10.1177/20552076231218150.


Continuous theta burst stimulation over right cerebellum for speech impairment in Parkinson's disease: study protocol for a randomized, sham-controlled, clinical trial.

Zhu X, Dai G, Wang M, Tan M, Li Y, Xu Z Front Aging Neurosci. 2023; 15:1215330.

PMID: 37655339 PMC: 10465698. DOI: 10.3389/fnagi.2023.1215330.


Crowdsourced Perceptual Ratings of Voice Quality in People With Parkinson's Disease Before and After Intensive Voice and Articulation Therapies: Secondary Outcome of a Randomized Controlled Trial.

McAllister T, Nightingale C, Moya-Gale G, Kawamura A, Ramig L J Speech Lang Hear Res. 2023; 66(5):1541-1562.

PMID: 37059078 PMC: 10457080. DOI: 10.1044/2023_JSLHR-22-00694.